Norris Medicines Share Price History and Returns 2014 to 2024
Norris Medicines Limited | |||
 | Price: ₹18.04 | ||
| 52 Week Low: ₹10.70 52 Week High: ₹27.74 | |||
| Market Capital: N/A | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Norris Medicines Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Norris Medicines Recent Performance
- 3: Norris Medicines Stock Price Chart From 2014 to 2024
- 4: Norris Medicines Stock Price History Table From 2014 to 2024
- 5: Analyzing the Impact of Investing in Norris Medicines
- 5.1: Norris Medicines Stock Returns In Last 5 Years
- 6: Norris Medicines Returns vs Bank FD Returns
Norris Medicines Stock Highlights
As of 26 Dec 2024, Norris Medicines Stock price is ₹18.04 which is ₹9.70 below 52-week high of ₹27.74 and ₹7.34 above 52-week low of ₹10.70
52-Week High Low
- Norris Medicines 52-Week High is ₹27.74 occurred on 14 Nov 2024
- Norris Medicines 52-Week Low is ₹10.70 occurred on 15 May 2024
All Time High
- The all-time high or the highest price that Norris Medicines stocks have ever touched was ₹1,693.00 and this occurred on 26 Dec 2024.
- The highest closing price at which Norris Medicines stocks have ever closed was ₹1,693.00 recorded on 26 Dec 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Norris Medicines Recent Performance
Over the past 15 trading days, the value of Norris Medicines's stock has decreased by ₹5.12 (-22.11%). On 05 Dec 2024, its one share was worth ₹23.16 and by 26 Dec 2024, the value dropped to ₹18.04. During this period it created a highest high of ₹23.16 and lowest low of ₹18.04.
Click on legend items to show/hide respective price lines
Norris Medicines Stock Price Chart From 2014 to 2024
Click on legend items to show/hide respective price lines
Norris Medicines Stock Price History Table From 2014 to 2024
| Year | Norris Medicines | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹18.04 | 35.9% | ↑ ₹27.74 ↓ ₹10.70 |
| 2023 | ₹13.27 | -6.6% | ↑ ₹15.80 ↓ ₹10.00 |
| 2022 | ₹14.20 | 32.7% | ↑ ₹36.75 ↓ ₹8.09 |
| 2021 | ₹10.70 | 72.5% | ↑ ₹13.89 ↓ ₹5.51 |
| 2020 | ₹6.20 | 63.1% | ↑ ₹6.20 ↓ ₹2.45 |
| 2019 | ₹3.80 | -23.3% | ↑ ₹10.61 ↓ ₹3.11 |
| 2018 | ₹4.95 | -99.8% | ↑ ₹26.00 ↓ ₹4.10 |
| 2016 | ₹1,693.00 | - | ↑ ₹1,693.00 ↓ ₹1,693.00 |
| 2015 | ₹1,693.00 | - | ↑ ₹1,693.00 ↓ ₹1,693.00 |
| 2014 | ₹1,693.00 | - | ↑ ₹1,693.00 ↓ ₹1,693.00 |
Analyzing the Impact of Investing in Norris Medicines
Norris Medicines Stock price in the year 2014 was ₹1,693.00. If you had invested ₹10,000 in Norris Medicines Stock in 2014, in 10 years, your investment would have reduced to ₹106 by the end of 2024. This represents a negative return of -99.0% from 2014 to 2024, with a compound annual growth rate (CAGR) of -36.6%.
Norris Medicines Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹36.75 and lowest was: ₹2.45
- Norris Medicines Stock price in 2019 was ₹3.80
- By 2024, its stock price rose to ₹18.04
- It gave a positive return of over 374.7% with a CAGR of 36.5% over the last 5 years
- If you had invested ₹10,000 in Norris Medicines in 2019 then in 5 years, your investment would have grown to ₹47,473.68 by 2024, which is 4.75 times of your initial investment.
Norris Medicines Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Norris Medicines Shares | ₹10,000 | ₹106.55 | -98.9% |
| Bank FD (Simple Interest) | ₹10,000 | ₹16,000 | 60.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹17,908.47 | 79.1% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
